| Name | Title | Contact Details |
|---|
Micromedics is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Built for surgeons by surgeons, Theator is pioneering the Surgical Intelligence Revolution, empowering surgeons everywhere to raise their expertise to the highest possible level.
Goode Consulting Intl is a Pompano Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
High-performing pharmacy is who we are At Visante, we believe in moving healthcare forward through innovative solutions that deliver lasting results. For over 20 years, we`ve been advancing the business of pharmacy™ by helping our clients deliver compliant services and products that foster growth and improve patient care. Our firm focuses on three areas of medication management: hospitals and health systems, pharmaceutical industry and managed care/government programs. Integrated health networks (IDNs), hospitals and health systems know us for our expertise to maximize lasting growth in 340B programs, specialty pharmacy, pharmacy assessments, sterile compounding and drug diversion. In addition, through our partner PharmacyStars, we provide a platform of technology solutions for our hospital and health system clients to maximize compliance in the areas of 340B, sterile compounding, drug diversion and more. Our managed care and government programs experts are here to help you navigate complex, changing requirements to reach compliance goals. Specializing in Medicare Parts C and D consulting, we can help you prepare for audits by the Centers for Medicare and Medicaid Services (CMS), conduct mock audits, improve operations, and maintain compliance. No matter how complex your compliance issues and operational needs are, we`re here to implement quality, cost-effective solutions. Visante consists of more than 60 consultants across the U.S., Canada, and the U.K., all working together to provide expert guidance from a wide range of disciplines, including pharmacy, nursing, operations, and information technology. We`re here to move the practice of pharmacy in the right direction.
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III